The present stock price for Summit Therapeutics Inc (SMMT) is $25.87. In the last trading session, the stock made a considerable jump, reaching $43.71 after an opening price of $25.87. The stock briefly fell to $12.04 before ending the session at $25.35.
Summit Therapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $36.91 on 04/24/25, while the lowest value for the same period was recorded at $11.76 on 09/05/24.
52-week price history of SMMT Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Summit Therapeutics Inc’s current trading price is -29.91% away from its 52-week high, while its distance from the 52-week low is 119.98%. The stock’s price range during this period has spanned from $11.76 to $36.91. In the Healthcare sector, the Summit Therapeutics Inc’s shares surpassed a trading volume of approximately 2.47 million for the day, which was noticeably lower compared to the average daily volume of 9.3.89 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Summit Therapeutics Inc (SMMT) has experienced a quarterly rise of 6.07% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 19.21B and boasts a workforce of 159 employees.
A Closer Look at Analysts’ Ratings for Summit Therapeutics Inc
As of right now, 8 analysts are rating Summit Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 24.01, with a change in price of +5.27. Similarly, Summit Therapeutics Inc recorded 4,316,958 in trading volume during the last 100 days, posting a change of +25.58%.
Examining SMMT’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for SMMT stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
SMMT Stock Stochastic Average
Today’s raw stochastic average for Summit Therapeutics Inc over the last 50 days is 56.62%.This indicates a increase from the raw stochastic average of the past 20 days, which was 25.07%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 24.58% and 29.05%, respectively.
SMMT Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 123.02% this year. Over the last six months, there has been a weaker performance of 19.77%. The price of SMMT leaped by -2.52% during the last 30 days period. For the last 5-days stocks have slided -3.72%.
